201 related articles for article (PubMed ID: 34261998)
21. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping.
Solimini R; Rotolo MC; Mastrobattista L; Mortali C; Minutillo A; Pichini S; Pacifici R; Palmi I
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):7-16. PubMed ID: 28379599
[TBL] [Abstract][Full Text] [Related]
22. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse.
Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS
Eur Psychiatry; 2006 Dec; 21(8):551-62. PubMed ID: 16356691
[TBL] [Abstract][Full Text] [Related]
23. Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users.
Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):e339-e344. PubMed ID: 35473322
[No Abstract] [Full Text] [Related]
24. [Anabolic androgenic steroids in amateur sports in the Netherlands].
Woerdeman J; de Hon O; Levi M; de Ronde WP
Ned Tijdschr Geneeskd; 2010; 154():A2004. PubMed ID: 20858322
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review.
Abrahin OS; Sousa EC; Santos AM
Subst Use Misuse; 2014 Jul; 49(9):1156-62. PubMed ID: 24766401
[TBL] [Abstract][Full Text] [Related]
26. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?
Kanayama G; Hudson JI; Pope HG
Drug Alcohol Depend; 2008 Nov; 98(1-2):1-12. PubMed ID: 18599224
[TBL] [Abstract][Full Text] [Related]
27. Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes.
Christou GA; Christou MA; Žiberna L; Christou KA
Eur J Sport Sci; 2019 Oct; 19(9):1276-1286. PubMed ID: 30880613
[TBL] [Abstract][Full Text] [Related]
28. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.
Nieschlag E; Vorona E
Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946
[TBL] [Abstract][Full Text] [Related]
29. Anabolic-androgenic steroids (AAS) users on AAS use: Negative effects, 'code of silence', and implications for forensic and medical professionals.
Richardson A; Antonopoulos GA
J Forensic Leg Med; 2019 Nov; 68():101871. PubMed ID: 31557629
[TBL] [Abstract][Full Text] [Related]
30. Adverse effects of doping with anabolic androgenic steroids in competitive athletics, recreational sports and bodybuilding.
Vorona E; Nieschlag E
Minerva Endocrinol; 2018 Dec; 43(4):476-488. PubMed ID: 29463075
[TBL] [Abstract][Full Text] [Related]
31. Illicit anabolic-androgenic steroid use.
Kanayama G; Hudson JI; Pope HG
Horm Behav; 2010 Jun; 58(1):111-21. PubMed ID: 19769977
[TBL] [Abstract][Full Text] [Related]
32. [Anabolic steroids in athletes].
Yesalis CE; Wright JE; Lombardo JA
Wien Med Wochenschr; 1992; 142(14):298-308. PubMed ID: 1441566
[TBL] [Abstract][Full Text] [Related]
33. Androgenic steroid excess in women.
Karila D; Kerlan V; Christin-Maitre S
Ann Endocrinol (Paris); 2024 Apr; 85(2):142-149. PubMed ID: 38040089
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
[TBL] [Abstract][Full Text] [Related]
35. American College of Sports Medicine position stand on the use of anabolic-androgenic steroids in sports.
Med Sci Sports Exerc; 1987 Oct; 19(5):534-9. PubMed ID: 3316907
[No Abstract] [Full Text] [Related]
36. Advances in the detection of designer steroids in anti-doping.
Abushareeda W; Fragkaki A; Vonaparti A; Angelis Y; Tsivou M; Saad K; Kraiem S; Lyris E; Alsayrafi M; Georgakopoulos C
Bioanalysis; 2014 Mar; 6(6):881-96. PubMed ID: 24702116
[TBL] [Abstract][Full Text] [Related]
37. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
[No Abstract] [Full Text] [Related]
38. Aortic elastic properties in athletes using anabolic-androgenic steroids.
Kasikcioglu E; Oflaz H; Arslan A; Topcu B; Kasikcioglu HA; Umman B; Bugra Z; Kayserilioglu A
Int J Cardiol; 2007 Jan; 114(1):132-4. PubMed ID: 16364476
[TBL] [Abstract][Full Text] [Related]
39. Short QT interval is unreliable marker of anabolic androgenic steroid abuse in competitive athletes.
Djordjević V; Stanković I; Stipac AV; Putniković B; Nesković AN
Srp Arh Celok Lek; 2012; 140(11-12):711-6. PubMed ID: 23350243
[TBL] [Abstract][Full Text] [Related]
40. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
Anawalt BD
Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
